360 ONE Quant Fund Direct-Growth
Equity: Thematic-Quant - Growth (Open ended) Factsheet
NAV: ₹19.52-0.68%
16 Jul 2026
Holdings Analysis
Equity, debt and cash allocation snapshot with market cap distribution for 360 ONE Quant Fund Direct-Growth.
Market Cap Distribution
Large Cap (71.7%)
Mid Cap (28.3%)
Historical Asset Allocation
| Asset | 30 Jun 2026 | 31 May 2026 | 30 Apr 2026 | 31 Mar 2026 | 28 Feb 2026 | 31 Jan 2026 |
|---|---|---|---|---|---|---|
| Equity | 99.53% | 99.50% | 99.16% | 98.93% | 98.78% | 99.38% |
| Debt | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Others (incl. cash) | 0.47% | 0.50% | 0.84% | 1.07% | 1.22% | 0.62% |
| Commodities | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Real Estate | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Portfolio Snapshot
No. of Securities
37
P/E Ratio
22.76
P/B Ratio
4.66
Top Holding %
3.68%
Top 5 Holdings %
17.06%
Top 10 Holdings %
32.67%
AUM
₹856 Cr
Expense Ratio
1.42%
Since Inception
15.55%
Max Drawdown
-0.22%
Alpha
3.63%
Sharpe Ratio
0.65
Top Portfolio Holdings by Weight
Latest portfolio holdings sorted by allocation weight. Includes instrument name, sector, number of shares, market value (₹ Cr) and percentage of net assets. Switch dates or categories using the controls below.
| Instrument | Sector | No. of Shares | Value (Rs. Cr) | Weight | Change |
|---|---|---|---|---|---|
| Polycab India Ltd. | Capital Goods | 31,681 | 31.56 | 3.68% | 0.19%↑ |
| Cholamandalam Investment and Finance Company Ltd. | Financial | 1,64,631 | 29.47 | 3.44% | 0.49%↑ |
| Aurobindo Pharma Ltd. | Healthcare | 1,83,873 | 29.03 | 3.39% | 0.37%↑ |
| Torrent Pharmaceuticals Ltd. | Healthcare | 61,315 | 28.33 | 3.31% | 0.16%↑ |
| Marico Ltd. | Consumer Staples | 3,31,972 | 27.76 | 3.24% | 0.06%↑ |
| Cummins India Ltd. | Capital Goods | 48,755 | 27.59 | 3.22% | -0.12%↓ |
| Bajaj Finance Ltd. | Financial | 2,74,361 | 27.57 | 3.22% | 0.32%↑ |
| Solar Industries India Ltd. | Chemicals | 14,058 | 26.28 | 3.07% | 0.08%↑ |
| REC Ltd. | Financial | 7,21,070 | 26.23 | 3.06% | 0.26%↑ |
| Divis Laboratories Ltd. | Healthcare | 39,502 | 25.99 | 3.03% | -0.03%↓ |
| Titan Company Ltd. | Consumer Discretionary | 58,255 | 25.66 | 3.00% | 0.26%↑ |
| Eicher Motors Ltd. | Automobile | 36,144 | 25.57 | 2.99% | -0.04%↓ |
| TVS Motor Company Ltd. | Automobile | 73,601 | 25.47 | 2.97% | 0.10%↑ |
| ICICI Lombard General Insurance Company Ltd. | Insurance | 1,45,044 | 25.26 | 2.95% | -0.04%↓ |
| HDFC Asset Management Company Ltd. | Financial | 94,761 | 25.14 | 2.94% | -0.02%↓ |
| Ashok Leyland Ltd. | Automobile | 15,85,545 | 25 | 2.92% | 0.05%↑ |
| SBI Life Insurance Company Ltd. | Insurance | 1,41,230 | 24.94 | 2.91% | -0.10%↓ |
| Bajaj Auto Ltd. | Automobile | 25,549 | 24.82 | 2.90% | -0.18%↓ |
| Nestle India Ltd. | Consumer Staples | 1,75,263 | 24.63 | 2.88% | 0.01%↑ |
| Bharat Electronics Ltd. | Capital Goods | 5,95,844 | 24.54 | 2.86% | 0.01%↑ |
1 / 2
Sector-wise Portfolio Allocation
Equity exposure by sector as a percentage of total net assets, tracked across recent portfolio dates. Identifies concentration risk and sector rotation trends in the fund's holdings.
| Sector | 30 Jun 2026 | 31 May 2026 | 30 Apr 2026 | 31 Mar 2026 | 28 Feb 2026 | 31 Jan 2026 |
|---|---|---|---|---|---|---|
| Financial | 19.90% | 19.13% | 19.59% | 18.93% | 19.56% | 20.12% |
| Automobile | 14.59% | 14.70% | 20.24% | 20.57% | 21.32% | 21.08% |
| Healthcare | 11.27% | 10.73% | 10.37% | 10.83% | 9.77% | 9.56% |
| Capital Goods | 9.77% | 9.69% | 13.18% | 12.60% | 12.41% | 11.22% |
| Consumer Staples | 8.81% | 8.76% | 9.37% | 9.43% | 8.95% | 8.99% |
| Metals & Mining | 8.30% | 8.87% | 3.36% | 3.67% | 3.64% | 3.45% |
| Insurance | 5.86% | 6.00% | 5.39% | 5.73% | 5.80% | 6.00% |
| Materials | 5.33% | 5.83% | - | - | - | - |
| Energy | 3.16% | 3.16% | 5.16% | 5.08% | 5.85% | 5.80% |
| Chemicals | 3.07% | 2.99% | 10.15% | 9.74% | 9.32% | 10.09% |
| Consumer Discretionary | 3.00% | 2.73% | - | - | - | - |
| Communication | 2.85% | 3.17% | - | - | - | - |
| Technology | 2.84% | 2.96% | 2.35% | 2.34% | 2.15% | 3.06% |
| Services | 0.78% | 0.77% | - | - | - | - |
Equity Insights
A detailed look at the equity holdings of this scheme — aggregated scores on value, momentum, quality parameters along with diversification and performance analysis.
Style Analysis
Value score
39.8 / 100
Weighted average Value score is 39.8. This indicates that portfolio is relatively reasonably valued using composite of value measures.
Price Momentum score
58.4 / 100
Weighted average Price Momentum score is 58.4. This indicates that portfolio has average momentum using composite of momentum measures.
Quality score
77.0 / 100
Weighted average Quality score is 77.0. This indicates that portfolio has high quality using composite of quality measures.
QVM score
63.7 / 100
Weighted average QVM score is 63.7. This indicates that portfolio has average QVM score and hence a neutral stance is warranted.
Red Flags
Frequently Asked Questions
What are the top holdings of 360 ONE Quant Fund Direct-Growth?
The top holdings of 360 ONE Quant Fund Direct-Growth as of 30 Jun 2026 are Polycab India Ltd. (3.68%), Cholamandalam Investment and Finance Company Ltd. (3.44%), Aurobindo Pharma Ltd. (3.39%), Torrent Pharmaceuticals Ltd. (3.31%), Marico Ltd. (3.24%). These top 5 stocks together account for 17.06% of the total portfolio. You can view the complete holdings breakdown above.
How many stocks does 360 ONE Quant Fund Direct-Growth hold in its portfolio?
360 ONE Quant Fund Direct-Growth holds 37 stocks in its portfolio as of 30 Jun 2026. The fund's portfolio size reflects the fund manager's investment approach, a more concentrated portfolio indicates higher conviction bets, while a larger number of holdings suggests a more diversified strategy.
What is the sector allocation of 360 ONE Quant Fund Direct-Growth?
As of 30 Jun 2026, 360 ONE Quant Fund Direct-Growth's top sector allocations are Financial (19.90%), Automobile (14.59%), Healthcare (11.27%). You can find detailed sector allocation above.
What is the equity and debt allocation of 360 ONE Quant Fund Direct-Growth?
As of 30 Jun 2026, 360 ONE Quant Fund Direct-Growth has 99.53% allocated to equity, and 0.00% to debt. You can also check the historical trends above.
What is the market cap allocation of 360 ONE Quant Fund Direct-Growth?
As of 30 Jun 2026, 360 ONE Quant Fund Direct-Growth's market cap allocation is 71.72% in large caps, 28.28% in mid caps, and - in small caps.
What is the PE ratio of 360 ONE Quant Fund Direct-Growth's portfolio?
The portfolio PE ratio of 360 ONE Quant Fund Direct-Growth is 22.76 as of 30 Jun 2026. The portfolio PE ratio tells you how expensive or cheap the fund's holdings are relative to their earnings.
What is the credit quality of 360 ONE Quant Fund Direct-Growth?
A credit rating breakdown is not available for 360 ONE Quant Fund Direct-Growth — its non-equity allocation was 0.00% as of the latest disclosure. This is common when a fund's non-equity holdings are mostly cash or short-term money market instruments, which aren't assigned a credit rating the way bonds are.
When is the latest portfolio disclosure for 360 ONE Quant Fund Direct-Growth?
The latest portfolio disclosure for 360 ONE Quant Fund Direct-Growth is as of 30 Jun 2026. SEBI requires all mutual funds to disclose their complete portfolio holdings on a monthly basis, typically within 10 days of the end of each month.